LOAMU
REGN icon

Lombard Odier Asset Management (USA)’s Regeneron Pharmaceuticals REGN Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,500
Closed -$3.64M – 311
2020
Q3 		$3.64M Hold
6,500
– – 0.24% 100
2020
Q2 		$4.05M Buy
+6,500
New +$3.69M 0.28% 91

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s REGN Position: Q1 2026 in Review

Lombard Odier Asset Management (USA) opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 395 shares worth $305K. The stake represents 0.03% of the portfolio and ranks #185 among its holdings. This is a return to the name: Lombard Odier Asset Management (USA) previously reported a position in REGN as recently as Q3 2025.

Lombard Odier Asset Management (USA) first reported a position in REGN in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.35M in Q3 2020. 1,396 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Lombard Odier Asset Management (USA) held 395 shares of Regeneron Pharmaceuticals worth $305K as of Q1 2026.
  • Regeneron Pharmaceuticals was a new Lombard Odier Asset Management (USA) position in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.03% of Lombard Odier Asset Management (USA)'s portfolio in Q1 2026, its #185 holding.
  • Lombard Odier Asset Management (USA) first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
  • Lombard Odier Asset Management (USA)'s Regeneron Pharmaceuticals position peaked at $1.35M in Q3 2020.
  • 1,396 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2026, filed 15 May 2026.